Renal Cancer - Results from #5900

Pharmacotherapies for renal cell carcinoma in Japan December 21, 2015

Genetic alteration in notch pathway is associated with better prognosis in renal cell carcinoma December 21, 2015

Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras December 14, 2015

Clinicopathological and prognostic value of programmed death ligand-1 (PD-L1) in renal cell carcinoma: a meta-analysis December 11, 2015

Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial December 11, 2015

Targeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinoma December 11, 2015

Managing older patients with hemophilia December 10, 2015

Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas December 10, 2015

Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014 December 10, 2015

Cancer Metastases: Early Dissemination and Late Recurrences December 10, 2015

Prognostic Biomarkers for Response to Vascular Endothelial Growth Factor-Targeted Therapy for Renal Cell Carcinoma December 2, 2015

Multiple Discordant Histology After Nephrectomy: Descriptive Analysis and Outcomes December 2, 2015

Diagnosis of Renal Cell Carcinoma: A Clinician's Perspective December 2, 2015

Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma December 2, 2015

Chemopreventive efficacy of hesperidin against chemically induced nephrotoxicity and renal carcinogenesis via amelioration of oxidative stress and modulation of multiple molecular pathways November 26, 2015

The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy November 25, 2015

Extreme Obesity Does Not Predict Poor Cancer Outcomes Following Surgery for Renal Cell Cancer November 25, 2015

AGS16F is a Novel Antibody Drug Conjugate Directed Against ENPP3 for the Treatment of Renal Cell Carcinoma November 25, 2015

The heterogeneity of radiologic response with anti-PD-1/PD-L1 therapy in metastatic Renal Cell Carcinoma (mRCC) November 24, 2015

Opdivo to treat advanced form of kidney cancer approved by the FDA November 24, 2015

Page 296 of 456